DPP4 and B-cell chronic lymphocytic leukemia: T-cell-focused studies have further indicated the CLL-associated depletion of polyfunctional CD26+ T cells, which represent another possible target for adoptive cell therapy (243) and unique subsets and transcriptional signatures of T cells in CLL patients (244).